| |||||||||||||||||||||||||||||||||||
Study ID | Study | Experiment Name | Experiment Notes | Strain Ont ID | Strain | Sex | Age | # of Animals | Sample Notes | Clinical Measurement Ont ID | Phenotype | Formula | Clinical Measurement Notes | Average Type | Value | Units | SEM | SD | Method Ont ID | Method | Method Site | Method Duration | Method Notes | Post Insult Type | Post Insult Time Value | Post Insult Time Unit | Conditions | Record ID | |||||||
1638 | Korbolina EE, et al., Aging (Albany NY). 2012 Jan;4(1):49-59. | retina integrity trait | RS:0000634 | OXYS/Nov | male | 90 days | 36 | CMO:0002453 | percentage of study population developing retinopathy during a period of time | 0.0247 | % | 0.0024 | 0.0144 | MMO:0000551 | slit-lamp direct ophthalmoscopy | 0.0 | Beta direct ophthalmoscope (Germany) | control condition | 85622 | control condition | |||||||||||||||
1638 | Korbolina EE, et al., Aging (Albany NY). 2012 Jan;4(1):49-59. | retina integrity trait | RS:0000634 | OXYS/Nov | female | 90 days | 25 | CMO:0002453 | percentage of study population developing retinopathy during a period of time | 0.0464 | % | 0.0028 | 0.014 | MMO:0000551 | slit-lamp direct ophthalmoscopy | 0.0 | Beta direct ophthalmoscope (Germany) | control condition | 85623 | control condition |